Risks of Retinal Vascular Occlusions with the Systemic Use of Tyrosine Kinase Inhibitors
Ophthalmology Retina · 2026-07 · 10 (7) · 734-744
DOI: 10.1016/j.oret.2026.02.019 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Ophthalmology Retina, 2026-07. Verfasst von Hejin Jeong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Case Western Reserve University School of Medicine, Cleveland, Ohio; Center for Ophthalmic Bioinformatics, Cole Eye Institute, Cleveland Clinic, Clev…. Hauptthemen laut MEDLINE: Retinal Vein Occlusion, Protein Kinase Inhibitors, Retinal Artery Occlusion, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, NCATS NIH HHS, Research to Prevent Blindness.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Case Western Reserve University School of Medicine, Cleveland, Ohio; Center for Ophthalmic Bioinformatics, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio.
- Case Western Reserve University School of Medicine, Cleveland, Ohio.
- Center for Clinical Informatics Research and Education, MetroHealth System, Cleveland, Ohio; Departments of Internal Medicine, Pediatrics, and Population and Quantitative Health Sciences, Case Western Reserve University…
- Mass Eye and Ear, Mass General Brigham, Boston, Massachusetts; Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts.
- Center for Ophthalmic Bioinformatics, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio; Cleveland Clinic Cole Eye Institute, Cleveland, Ohio; Cleveland Clinic Lerner College of Medicine of Case Western Reserve Univ…
Förderung
- NEI NIH HHS
- NCATS NIH HHS
- Research to Prevent Blindness
- National Institutes of Health
- Cleveland Eye Bank Foundation
- Case Western Reserve University Clinical and Translational Science Collaborative
- National Center for Advancing Translational Sciences
Zitieren
APA
Jeong, H., Yue, S. C., Kaelber, D. C., Singh, R. P., & Talcott, K. E. (2026). Risks of Retinal Vascular Occlusions with the Systemic Use of Tyrosine Kinase Inhibitors. Ophthalmology Retina, 10(7), 734-744. https://doi.org/10.1016/j.oret.2026.02.019
Vancouver
Jeong H, Yue SC, Kaelber DC, Singh RP, Talcott KE. Risks of Retinal Vascular Occlusions with the Systemic Use of Tyrosine Kinase Inhibitors. Ophthalmology Retina. 2026;10(7):734-744. doi:10.1016/j.oret.2026.02.019
BibTeX
@article{Jeong2026,
author = {Jeong, Hejin and Yue, Sophie C and Kaelber, David C and Singh, Rishi P and Talcott, Katherine E},
title = {Risks of Retinal Vascular Occlusions with the Systemic Use of Tyrosine Kinase Inhibitors},
journal = {Ophthalmology Retina},
year = {2026},
volume = {10},
number = {7},
pages = {734--744},
doi = {10.1016/j.oret.2026.02.019}
}
EUVIMED